Drug Shortage Report for APO-NAPRO-NA DS

Last updated on 2023-07-27 History
Report ID 193215
Drug Identification Number 01940309
Brand name APO-NAPRO-NA DS
Common or Proper name NAPROXEN NA
Company Name APOTEX INC
Market Status MARKETED
Active Ingredient(s) NAPROXEN SODIUM
Strength(s) 550MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size 100 BTL
ATC code M01AE
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2023-05-23
Estimated end date 2023-07-28
Actual end date 2023-07-26
Shortage status Resolved
Updated date 2023-07-27
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 150 SIGNET DRIVE
Company contact information Apotex Customer Service - 1-877-427-6839

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v16 2023-07-27 French Compare
v15 2023-07-27 English Compare
v14 2023-07-27 French Compare
v13 2023-07-27 English Compare
v12 2023-07-27 French Compare
v11 2023-07-27 English Compare
v10 2023-07-27 English Compare
v9 2023-07-27 French Compare
v8 2023-07-27 English Compare
v7 2023-07-27 English Compare
v6 2023-07-07 French Compare
v5 2023-07-07 English Compare
v4 2023-06-29 French Compare
v3 2023-06-29 English Compare
v2 2023-05-26 French Compare
v1 2023-05-26 English Compare

Showing 1 to 16 of 16